UK Hearing Loss Disease Treatment Market Size & Outlook
UK hearing loss disease treatment market, 2018-2030 (US$M)
Related Markets
UK hearing loss disease treatment market highlights
- The UK hearing loss disease treatment market generated a revenue of USD 1,376.8 million in 2023 and is expected to reach USD 1,864.4 million by 2030.
- The UK market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
- In terms of segment, devices was the largest revenue generating product in 2023.
- Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Hearing loss disease treatment market data book summary
| Market revenue in 2023 | USD 1,376.8 million |
| Market revenue in 2030 | USD 1,864.4 million |
| Growth rate | 4.4% (CAGR from 2023 to 2030) |
| Largest segment | Devices |
| Fastest growing segment | Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Devices, Drugs |
| Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, UK accounted for 10.1% of the global hearing loss disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany hearing loss disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,083.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hearing Loss Disease Treatment Market Scope
Hearing Loss Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK hearing loss disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.94% in 2023. Horizon Databook has segmented the UK hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
According to estimate published by Royal National Institute for Deaf People, by 2035, UK is expected to witness an estimated 14.2 million adults with hearing loss. To deal with this health condition, several developments by market players and the government are being conducted, which will eventually drive the market.
In April 2019, Starkey announced the launch of its very first AI-based hearing aid in the UK. Furthermore, in June 2022, Sonova UK announced the launch of its new hearing technology in the UK. Moreover, government and healthcare authorities are focusing on introducing new therapeutics for treatment of hearing loss in the UK.
For instance, in February 2023, United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) approved UK clinical trial for Decibel Therapeutics’ DB-OTO for hearing loss. Moreover, in May 2022, Rinri Therapeutics received approval from MHRA for its cell therapy, targeting hearing loss.
Reasons to subscribe to UK hearing loss disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK hearing loss disease treatment market databook
-
Our clientele includes a mix of hearing loss disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into UK hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK hearing loss disease treatment market report size, by product, 2018-2030 (US$M)
UK Hearing Loss Disease Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
